Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Refining diagnosis of multiple sclerosis with revised MRI criteria.
Receptos Initiates SUNBEAM Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis
Monoclonal antibodies conjugated with superparamagnetic iron oxide particles allow magnetic resonance imaging detection of lymphocytes in the mouse brain.
Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.
Prospective memory, emotional valence, and multiple sclerosis.
Mitoxantrone-induced suicidal erythrocyte death.
Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.
Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth.
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study.
Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta™, for Multiple Sclerosis
Uhthoff's phenomena in MS-clinical features and pathophysiology.
Oligodendrocyte death results in immune-mediated CNS demyelination.
FDA denies Teva Copaxone generic trials petition
Altered Expression of Oligodendrocyte and Neuronal Marker Genes Predicts the Clinical Onset of Autoimmune Encephalomyelitis and Indicates the Effectiveness of Multiple Sclerosis-Directed Therapeutics.
LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL.
Therapeutic class review, Neurological - multiple sclerosis dalfampridine (Ampyra(TM))
Predictive value of early brain atrophy on response in patients treated with interferon β.
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Toxicity of Teriflunomide in Aryl Hydrocarbon Receptor Deficient Mice.
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.
Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients.
Novel MS Drug Offers Good Functional Outcomes

Pages